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Abbreviations:  
COPSAC2000 = COpenhagen Prospective Studies on Asthma in Childhood2000 COPSAC2010 = 
COpenhagen Prospective Studies on Asthma in Childhood2010 
H. influenzae= Haemophilus influenzae 
M. catharralis = Moraxella catharralis 
S. pneumoniae= Streptococcus pneumoniae 
hs-CRP = High sensitivity CRP 
IL-6 = Interleukin-6 
TNF-a = Tumor Necrosis Factor alpha 
qPCR = Quantitative Polymerase Chain Reaction 
 
ABSTRACT  
Background and Objectives: The development of childhood asthma is associated with neonatal 
colonization with pathogenic bacteria in hypopharynx. Furthermore, established asthma is 
associated with systemic low-grade inflammation. We here report on the association between 
neonatal colonization with pathogenic bacteria in hypopharynx and the development of systemic 
low-grade inflammation. 
 
Methods: Bacterial colonization of the hypopharynx with M. catharralis, H. influenzae and/or S. 
pneumoniae was assessed in asymptomatic children from the Copenhagen Prospective Studies on 
Asthma in Childhood2000 (COPSAC2000) cohort at age 1 month by culturing technique (N=238) and 
by quantitative polymerase chain reaction (qPCR) technique (N=249) and in the COPSAC2010 
cohort by culturing at age 1 month (N=622) and again at age 3 months (N=613). Systemic low-
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grade inflammation was determined in both cohorts at age 6 months by measuring plasma levels 
of high-sensitivity C-reactive protein (hs-CRP), tumor necrosis factor-α (TNF-α) and interleukine-6 
(lL-6).  
Results: In both cohorts, bacterial colonization was associated with increased levels of hs-CRP: 
COPSAC2000, 1 month culturing (geometric mean ratio of colonized/non-colonized [95% CI]), 1.39 
[0.97–2.01], p=0.08, 1 month qPCR, 1.55 [1.14–2.10], p<0.01; COPSAC2010, 1 month, 1.52 [1.23–
1.87], p<0.01, and 3 month, 1.57 [1.30–1.90], p<0.01. A multi-parametric principal component 
analysis incorporating hs-CRP, TNF-α and IL-6 confirmed a systemic inflammatory profile in 
children colonized with M. catharralis, H. influenzae and/or S. pneumoniae in the hypopharynx 
compared to non-colonized children (p-values<0.05). 
 
Conclusion: The composition of the upper airway microbiome in early life may cause systemic 
low-grade inflammation.  
 
Keywords: asthma, clinical immunology, environment and hygiene hypothesis, innate immunity, 
pediatrics. 
INTRODUCTION 
Chronic inflammatory diseases such as asthma (1), allergy (2), chronic obstructive pulmonary 
disease (3), cardiovascular disease (4), obesity (5), and diabetes mellitus (6) have been reported 
to be associated with a low-grade systemic inflammation as reflected in elevated biomarkers such 
as high-sensitivity C-reactive protein (hs-CRP). This suggests a shared disease mechanism in 
chronic inflammatory disorders, which is proposed to be caused by alterations of the gut 
microbiome (7–9), and possibly the airway microbiome (10–12). 
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The airway microbiome of the hypopharynx in neonates has been associated with the 
development of childhood asthma (13,14). The airway microbiome is believed to play a key role 
regulating chronic airway inflammation (10,12), but it is unknown whether the early life airway 
microbiome is also associated with systemic low-grade inflammation. 
The aim of this study was to analyze systemic inflammation in neonates colonized in the upper 
airways with M. catharralis, H. influenzae and/or S. pneumonia. The analyses were performed in 
children in the at-risk mother-child cohort Copenhagen Prospective Studies on Asthma in 
Childhood, COPSAC2000, and replication was sought in the unselected COPSAC2010 mother-child 
cohort. 
 
METHODS 
Study Populations 
Data was obtained from the two ongoing clinical mother-child cohorts, COPSAC2000 and 
COPSAC2010, both from Zealand, Denmark. COPSAC2000 is a high-risk cohort including 411 children 
of asthmatic mothers, where exclusion criteria were any congenital abnormality, a gestational 
age below 36 weeks, and any respiratory symptoms before the inclusion visit at age one month 
(15). COPSAC2010 is a population-based cohort enrolling 738 pregnant women from 24 weeks of 
gestation and their 700 children. Exclusion criteria were women with any endocrine, heart, or 
kidney disorder or a vitamin D intake above 600 IU/d (16).  
The Local Ethics Committee (COPSAC2000: KF 01-289/96, COPSAC2010: H-B-2008-093) and the 
Danish Data Protection Agency (COPSAC2000 and COPSAC2010: 2015-41-3696) approved the studies. 
Both parents gave oral and written informed consent before enrolment. 
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Assessments of Bacterial Colonization of the Hypopharynx 
COPSAC2000: At the age of one month, an airway aspirate was sampled in asymptomatic neonates 
with a soft suction catheter passed through the nose into the hypopharynx (13–15). At the same 
visit, swaps were obtained from the nasopharynx by sterile ESwab (Copan Diagnostic Inc., CA 
USA) through the nasal cavity.  
COPSAC2010: Airway aspirates were collected at age one month and again at age three months 
from the hypopharynx using the same standard operating procedure as in COPSAC2000 described 
above.  
Microbial identification of M. catarrhalis, H. influenzae and S. pneumoniae was performed by 
culturing using standard methods using with non-selective and selective media, combined with 
characteristics of colonies, and cellular morphology (13,17,18). All bacterial identifications were 
confirmed biochemically by automated identification system VITEK 2 (Bio Mérieux, France).  
Swaps were analyzed by quantitative polymerase chain reaction (qPCR) for presence of M. 
catarrhalis, H. influenzae and/or S. pneumoniae, by targeting specific genes  with primers (see 
Online Supplement for details). In brief, qPCR assay results were analysed in Applied BioSystem 
7500 Software v2.0.6 (Life Technologies, Waltham, MA, USA) and considered positive at a 
threshold value of 0.2 genome equivalents per microliter (geq/µL) template DNA. 
 
Assessment of Systemic Inflammation 
Systemic inflammation was assessed at age 6 months in both cohorts by measuring plasma levels 
of blood inflammatory markers: hs-CRP, tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6). 
These biomarkers were chosen a priori as they are established measures of systemic 
inflammation (19,2). Blood was drawn from a cubital vein into an EDTA tube, centrifuged to 
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separate plasma and cells, and immediately stored at -80ºC until analysis. After thawing, 
biomarker levels were determined by a high sensitivity ELISA technique based on 
electrochemiluminescence. Samples were read in duplicate by using the Sector Image 2400A 
(Meso Scale Discovery, Gaitherburg, MD). Lower limit of detection (LLOD) was 0.007 ng/mL for 
hs-CRP, 0.093 pg/mL for TNF-α and 0.178 pg/mL for IL-6.  
 
Covariates  
Infections: Evaluation of infections was based on doctor diagnosis and symptoms documented in 
diaries. Symptoms monitored included upper and lower respiratory tract infections, 
gastroenteritis and fever with unknown cause. Current infection was defined as any such 
infection in a period of two weeks prior to blood sampling (14,15,20).  
Siblings included biologically or non-biologically related children, living at the child’s address 
during the child’s first year of life.  
 
Statistical Analysis 
Levels of hs-CRP, TNF-α and IL-6 were log-transformed prior to analysis and reported as median 
levels (interquartile range, IQR) (see online Table E1 for details). Before log-transformation, the 
lower limit of detection was added to all measurements as a pseudo-count to avoid zero values. 
Upper airway colonization with M. catarrhalis, H. influenzae and/or S. pneumoniae was analyzed 
as a dichotomous variable (colonized vs. non-colonized). Associations between bacterial 
colonization and inflammatory markers were examined separately in each cohort using general 
linear models for analyses adjusted for siblings (13,17) and current infections(21). All results are 
reported as adjusted geometric mean ratio (GMR) of colonized/non-colonized with 95% 
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confidence interval [CI]. Wilcoxon rank sum test was used for skewed data. In addition, we did a 
combined analysis of the bacterial culturing results from age one month in both cohorts with an 
inverse variance meta-analysis using the R-package “meta” (22). 
We also conducted a supplementary multi-parametric principal component analysis (PCA) in both 
cohort studies, including all biomarker levels of hs-CRP, IL-6 and TNF-α, and analyzed the 
relationship between bacterial colonization of the hypopharynx and principal component 1 (PC-
1). 
All analyses were done with SAS, version 9.4 (SAS institute, Cary, NC) or R version 3.2.3 (The R 
Foundation for Statistical Computing) (23) and visualized with the “ggplot2” package (24). Further 
details are given in the online repository. 
 
RESULTS 
Baseline Characteristics 
In COPSAC2000, 238 (58%) of the 411 children had data both on inflammatory biomarker levels and 
on bacterial colonization of hypopharynx determined by culturing technique, and 248 (60%) had 
data both on inflammatory biomarker levels and on bacterial colonization determined by qPCR 
technique.  
In COPSAC2010, 622 (89%) of the 700 children had data both on inflammatory biomarker levels and 
bacterial colonization at age 1 month, and 613 (88%) had data both on inflammatory biomarker 
levels and airway colonization at age 3 months (online Figure E1). 
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Infection in the 2-weeks before the time of blood sampling for assessment of inflammatory 
biomarker levels was reported for 122 (30%) of the included children in COPSAC2000 and 174 (31%) 
of the children in COPSAC2010. Children with infection vs. without infection in the 2-weeks before 
blood sampling had increased levels of hs-CRP, median (IQR): COPSAC2000, 0.43 mg/L [0.17–0.53] 
vs. 0.09 mg/L [0.04–0.32], p<0.01, and COPSAC2010, 0.04 mg/L [0.08–0.57] vs. 0.09 mg/L [0.05–
0.27], p<0.01. 
Baseline characteristics of included and excluded children from the two cohorts are described in 
Table 1, showing no significant differences between included and excluded children in the 
COPSAC2000 cohort. In the COPSAC2010 cohort, the included vs. excluded children were less often 
exposed to smoking during pregnancy (42 (7%) vs. 12 (15%), p=0.01) and had a higher gestational 
age (mean 279 days (SD, 11) vs. 276 (16), p=0.01).   
 
Bacterial Colonization and Systemic Low-grade Inflammation  
COPSAC2000: M. catarrhalis, H. influenzae and/or S. pneumoniae was detected in 52 (22%) of the 
238 cultured samples and in 86 (35%) of the 248 samples analyzed by qPCR. A total of 222 
children had samples analyzed by both qPCR and conventional culturing technique; 87 (39%) 
were positive by either method, 39 (17%) by both methods, whereas 38 (17%) were positive only 
by qPCR contrasting 10 (5%) only by culturing technique. 
Children who were colonized at age 1 month determined by culturing had a median [IQR] hs-CRP 
level at age 6 months of 0.30 mg/L  [0.08–0.51] compared to 0.13 mg/L [0.05–0.47] for non-
colonized children: GMR of colonized/non-colonized [95% CI], 1.4 [0.9–2.0], p=0.08. 
Level of hs-CRP was significantly elevated among children who were colonized at age 1 month 
determined by qPCR; median [IQR] hs-CRP level was 0.23 mg/L  [0.08–0.50] for colonized children 
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compared to 0.11 mg/L [0.04–0.38] for non-colonized children: GMR, 1.55 [1.1-2.1], p<0.01. 
Adjusting these analyses for infections and siblings resulted in similar results though with slightly 
lower estimates, particularly after adjustment for older siblings (Table 2). 
COPSAC2010: M. catarrhalis, H. influenzae and/or S. pneumoniae was detected by culturing in 182 
(29%) of 622 children at age 1 month and in 264 (43%) of 613 children at age 3 months. A total of 
319 (53%) children were colonized at one or both time points of whom 106/319 (33%) were 
colonized at both time points, 64/319 (20%) were only colonized at age 1 month, and 149/319 
(47%) were only colonized at age 3 months (online Table E2). Colonization at age 1 month was 
associated with increased hs-CRP,colonized vs. non-colonized, 0.23 mg/L  [0.07–0.53] vs. 0.10 
mg/L [0.05–0.38], GMR, 1.52 [1.2–1.9], p<0.01, with similar findings for colonization at age 3 
months, 0.22 mg/L  [0.07–0.52] vs. 0.09 mg/L [0.05–0.37]; GMR, 1.57 [1.30–1.90], p<0.01 (Figure 
1). Analyses adjusted for infections and siblings yielded similar results (Table 2). 
A sensitivity analysis excluding all samples from children with infections in the 2-weeks before the 
time of blood sampling for assessment of inflammatory biomarker levels showed a similar 
association between bacterial colonization and elevated levels of hs-CRP in both cohorts (Table 
3). 
Analyzing the hs-CRP data with non-parametric statistical tests yielded similar results (online 
Table E3). 
Adjusting the association between colonization at age 1 month and hs-CRP for colonization at age 
3 month and vice versa, still revealed significant associations from colonization at both time 
points, showing independent contribution to systemic low-grade inflammation from each time 
point.   
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A combined analysis of the age 1 month conventional culturing results from COPSAC2000 and 
COPSAC2010 showed that bacterial colonization was associated with elevated hs-CRP levels: GMR 
1.49, CI [1.3−1.8], p<0.01 (Table 2 and Figure 2). 
TNF-α and IL-6 blood levels showed similar results as hs-CRP, with increased levels in colonized vs. 
non-colonized children, but the associations were less significant (see online Figure E2). 
Analyzing the pathogen-specific associations between colonization with M. catarrhalis, H. 
influenzae or S. pneumoniae and hs-CRP levels showed similar trends of elevated hs-CRP, but less 
pronounced as the signal from colonization with either of the pathogens, which is presumably 
due to lower power in these subgroup analysis (online Table E4). Table E5 shows pathogen-
specific associations with IL-6 and TNF-α level. 
 
Multi-parametric PCA 
The multi-parametric PCA approach is a data-driven way to reduce the variance across the three 
different cytokines captured in PC-1, which is a proxy of  the overall inflammatory response.  
COPSAC2000: PC-1 from the multi-parametric PCA incorporating hs-CRP, IL-6 and TNF-α (Figure 3), 
explained 55% of the total variance in the biomarker data set. All three markers were positively 
correlated in PC-1, and especially IL-6 and hs-CRP were highly correlated. Bacterial colonization of 
hypopharynx determined by culturing at age 1 month was significantly associated with PC-1: 
GMR, 1.4 [1.0–1.9], p=0.04, with a similar association for qPCR results: GMR, 1.5 [1.2–1.9], 
p<0.01.  
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COPSAC2010: PC-1 from the PCA on the COPSAC2010 dataset also explained 55% of the variance. 
Colonization at age 1 month and 3 months were both significantly associated with the 
inflammatory profile represented by PC-1: GMR, 1.4 [1.2–1.7], p<0.01) and 1.5 [1.2–1.7], p<0.01, 
respectively (Table 4).  
PC-1 was stronger and more significantly associated with airway colonization than analyzing the 
cytokines separately with traditional univariate statistical approaches (online table E5 and Figure 
3).  
 
DISCUSSION  
Primary Findings 
Asymptomatic neonates colonized with M. catarrhalis, H. influenzae and/or S. pneumoniae in the 
upper airways have systemic low-grade inflammation. This was shown in a mother-child cohort 
at-risk of asthma and subsequently replicated in an unselected mother-child cohort, where 
asymptomatic bacterial colonization of hypopharynx at both 1 and 3 months was associated with 
increased hs-CRP levels, suggesting that a perturbed upper airway microbiome may cause a 
systemic low-grade inflammation.  
 
Strengths and Limitations 
A major advantage of the study is the unique data on bacterial upper airway colonization in 
asymptomatic neonates and assessment of blood inflammatory markers in infancy measured at 
similar age points in two independent birth cohorts. While COPSAC2000 is a high-risk birth cohort 
of children born to mothers with asthma, COPSAC2010 is a population-based cohort. The similar 
findings in these two cohorts confirm that the association between neonatal bacterial airway 
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colonization and a systemic low-grade inflammatory process is a true relation. The association in 
COPSAC2010 between colonization at age 3 months and systemic low-grade inflammation further 
supports a link between the upper airway microbiome and systemic inflammation. 
Both conventional culturing and qPCR techniques were applied in COPSAC2000 at age 1 month, 
whereas colonization data from COPSAC2010 at both age 1 month and 3 months were obtained by 
culturing, which is less sensitive than qPCR. This was illustrated by a stronger association between 
qPCR data and hs-CRP vs. culturing data and hs-CRP in COPSAC2000, whilst the culturing results 
from both age 1 month and 3 months in COPSAC2010 were strongly associated with elevated hs-
CRP, probably because of the higher numbers.  
The panel of bacteria assessed in this study only represents a small fraction of the complex 
biological composition of the diverse airway ecosystem of bacteria, fungi and viruses (25,26). We 
restricted the study to the three most common pathogenic airway bacteria (M. catarrhalis, H. 
influenzae and/or S. pneumoniae) because we previously demonstrated that colonization with 
either of these bacteria in the hypopharyngeal region was associated with development of 
childhood asthma (13). We assume that these bacteria originate from the lower airways, but the 
possibility of contamination from the oral/upper gastroentestinal microbiome cannot be ruled 
out. 
The measurement of inflammatory biomarkers was done three to five months after assessment 
of bacterial colonization, which can be seen as both strength and a limitation. Simultaneous 
assessments of microbes and systemic low-grade inflammation would have allowed a more direct 
evaluation of this relationship and ruled out that other factors led to or contributed to increased 
biomarker levels. Conversely, this temporal asynchronicity may suggest a more permanent 
inflammatory phenotype in the colonized children.  
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Detailed information from daily diary cards of common infections in early childhood allowed us to 
robustly adjust the analyses for infections in a 2-week time period before measurement of blood 
inflammatory biomarker levels, which did not alter the findings. The frequency of infections was 
high, but similar in the two independent cohorts, and was associated with increased levels of hs-
CRP.  
Adjusting the analyses for siblings, which in our date was associated with both bacterial 
colonization (13) and hs-CRP levels (19), resulted in slightly smaller effect sizes and loss of 
significance in some of the analyses, but did not affect the overall conclusions. This is interesting 
given the fact that siblings has been shown to decrease the risk of developing allergic rhinitis (27), 
which we have shown is associated with elevated hs-CRP levels at school-age (2). We speculate 
that the observation of association between siblings and hs-CRP levels in our study is driven by a 
relationship between siblings, an altered microbial exposure, and susceptibility to develop 
infections in early life. 
 
Interpretation  
Asymptomatic bacterial colonization in hypopharynx with M. catarrhalis, H. influenzae and/or S. 
pneumoniae at age one month and at age three months was independently associated with a 
systemic low-grade inflammation at six months of age. This may reflect an intermediary process 
between a perturbed upper airway microbiome and development of childhood asthma as 
systemic low-grade inflammation has previously been associated with asthma and decreased lung 
function in asthmatics (28).  
Emerging evidence indicates that altered microbial colonization patterns are involved in the 
physiologic, immunologic, and metabolic deregulation seen in asthma and other chronic 
inflammatory diseases (7,31–34). Most studies have focused on the role of the gut microbiome in 
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subjects with ongoing chronic inflammatory diseases, whereas few studies have investigated the 
airway microbiome and systemic inflammation in chronic inflammatory diseases (33,34), and no 
studies have investigated the relationship between the early life airway microbiome and systemic 
inflammation before disease development. 
We have previously demonstrated (13,35) and replicated (14) that asymptomatic bacterial 
colonization in hypopharynx at age one month was associated with the risk of recurrent wheeze, 
childhood asthma and lower respiratory tract infections. We also reported that polymorph blood 
mononuclear cells from children later developing asthma showed an exaggerated ex vivo 
response to the same airway bacteria at 6 months of age, i.e. before disease development 
(36,37). Further, we showed that bacterial colonization in hypopharynx was associated with a 
local up-regulation of pro-inflammatory immune mediators in the upper airways (17). The current 
study shows that colonization of the upper airways is also associated with a systemic low-grade 
inflammation.  
Despite the observational nature of the study it appears most likely that the causal direction is 
the airway microbiome causing a systemic low-grade inflammation, rather than the other way 
around. Thus, the specific composition of the upper airway microbiome characterized by 
presence of M. catarrhalis, H. influenzae and/or S. pneumoniae in hypopharynx may be 
speculated to induce an inflammatory airway response leading to a prolonged systemic low-grade 
inflammation and a trajectory towards childhood asthma. However, we cannot rule out that the 
indications of a local as well as a systemic inflammation is a reflection of a pre-existing aberrant 
immune system allowing pathogenic bacteria to establish themselves in the airways. 
Conclusion 
Pathogenic bacterial colonization of the upper airways in asymptomatic infants is associated with 
a systemic low-grade inflammation. This may reflect an intermediary process between a 
perturbed upper airway microbiome and development of childhood asthma.  
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TABELS  
Table 1. Baseline characteristics and comparison of included vs. excluded children from the 
COPSAC2000 and COPSAC2010 birth cohorts.  
 All children Included children Excluded children p 
COPSAC2000 cohort 411 248 163  
Infection at time of blood 
sampling (%) 
122 (29.7) 78 (32.8) 44 (25.4) 0.13 
Siblings at home (%) 160 (40.1) 100 (40.8) 60 (39.0) 0.79 
Smoking during pregnancy 
(%) 
99 (24.1) 65 (26.2) 34 (20.9) 0.26 
Passive smoke exposure (%) 311 (83.2) 191 (81.3) 120 (86.3) 0.26 
Cat in home (%) 61 (15.4) 36 (14.9) 25 (16.1) 0.85 
Dog in home (%) 55 (13.9) 34 (14.1) 21 (13.5) 0.97 
Natural (vaginal) birth (%) 324 (78.8) 194 (78.2) 130 (79.8) 0.80 
Breastfed length, days 
(median [IQR]) 
122 [90.0- 155.0] 122 [91.0 - 153.5] 122 [78.5-155.5] 0.93 
Daycare start age, days (mean 
(SD)) 
1.10 (0.80) 1.11 (0.78) 1.07 (0.83) 0.63 
Sex, Male (%) 203 (49.4) 130 (52.4) 73 (44.8) 0.16 
Birth weight (mean (SD)) 3.52 (0.52) 3.50 (0.51) 3.54 (0.53) 0.53 
Birth length (mean (SD)) 52.30 (2.31) 52.22 (2.28) 52.42 (2.37) 0.38 
Head circumference at birth 
(mean (SD)) 
352.17 (16.22) 351.84 (16.17) 352.66 (16.33) 0.63 
Gestational age, days (mean 
(SD)) 
282.11 (10.74) 282.16 (10.74) 282.04 (10.77) 0.92 
 All children Included children Excluded children p 
COPSAC2010 cohort 700 622 78  
Infection at time of blood 174 (31.2) 165 (31.6) 9 (25.0) 0.52 
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sampling (%) 
Siblings at home (%) 395 (56.4) 357 (57.4) 38 (48.7) 0.18 
Daycare start age, days (mean 
(SD)) 
326.29 (96.89) 327.30 (93.77) 318.10 (119.54) 0.43 
Passive smoke exposure (%) 374 (54.4) 340 (55.2) 34 (47.2) 0.25 
Smoking during pregnancy 
(%) 
54 ( 7.7) 42 (6.8) 12 (15.4) 0.01 
Natural (vaginal) birth (%) 549 (78.4) 489 (78.6) 60 (76.9) 0.84 
Cat in home (%) 151 (21.9) 135 (21.9) 16 (22.2) 1.00 
Dog in home (%) 150 (21.8) 134 (21.8) 16 (22.2) 1.00 
Athmatic mother (%) 186 (26.6) 162 (26.0) 24 (30.8) 0.45 
Breastfed length, days 
(median [IQR]) 
122 [46.0 - 150.0] 122 [57.7- 150.0] 116 [20.0-149.0] 0.09 
Gestational age in days (mean 
(SD)) 
279.00 (11.65) 279.40 (10.92) 275.78 (16.05) 0.01 
Birth length (mean (SD)) 51.87 (2.54) 51.90 (2.44) 51.62 (3.25) 0.35 
Birth weight (mean (SD)) 3.54 (0.55) 3.54 (0.53) 3.50 (0.66) 0.56 
Head circumference at birth 
(mean (SD)) 
35.00 (1.71) 34.99 (1.71) 35.05 (1.71) 0.76 
Sex, Male (%) 360 (51.4) 319 (51.3) 41 (52.6) 0.93 
Social circumstances, PCA 
score (mean (SD)) 
0.00(1.00) 0.00 (1.00) 0.03(1.03) 0.79 
 
 
 
Table 2. Association between early life bacterial airway colonization with M. catharralis, H. 
influenzae and/or S. pneumoniae and levels of hs-CRP at age 6 months in COPSAC2000, COPSAC2010 
and combined. 
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COPSAC2000: 
age 1 month 
Colonized 
(total n) 
Colonized, 
median [IQR] 
mg/L 
Non-colonized, 
median [IQR] 
mg/L 
GMR 
[95%CI] 
P 
Culture data 52 
(238) 
0.30 
 
[0.08 – 0.51] 
0.13 
 
[0.05 – 0.47] 
1.39 
[0.97 – 2.01] 
0.08 
Adjusted for current 
infections 
52 
(238) 
- - 1.30   
[0.92 – 1.84] 
0.12 
Adjusted for siblings 52 
(238) 
- - 1.11 
[0.74 – 1.65] 
0.60 
qPCR data 86 
(248) 
 0.23 
 
0.08 – 0.50] 
 0.11 
[0.04 – 0.38] 
1.55  
[1.14 – 2.10] 
<0.01 
Adjusted for current 
infections 
86 
(248) 
- - 1.48  
[1.09 - 2.00] 
0.01  
Adjusted for siblings 86 
(248) 
- - 1.33  
[0.95 – 1.87] 
0.09 
COPSAC2010: 
age 1 month 
Colonized 
(total n) 
Colonized, 
median [IQR] mg/L  
Non-colonized, 
median [IQR] mg/L  
GMR 
[95%CI] 
P 
Culture data 182 (622)  0.23 
[0.07 – 0.53] 
 0.10 
[0.05 – 0.38] 
1.52  
[1.24 – 1.87] 
<0.01 
Adjusted for current 
infections 
154 (530) - - 1.51  
[1.22 – 1.86] 
<0.01 
Adjusted for siblings 182 (622) - - 1.28  
[1.04  - 1.58] 
0.02 
COPSAC2010: 
age 3 months 
Colonized 
(total n) 
Colonized, 
median [IQR] mg/L  
Non-colonized, 
median [IQR] mg/L  
GMR 
[95%CI] 
P 
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Culture data 264 (613)   0.22 
[0.07 – 0.52] 
  0.09 
[0.05 – 0.37] 
1.57  
[1.30 – 1.90] 
<0.01 
Adjusted for current 
infections 
223(522) - - 1.56  
[1.29 – 1.89] 
<0.01 
Adjusted for siblings 264 (613) - - 1.32  
[1.08 - 1.61] 
<0.01 
Combined analysis of 
COPSAC2000 and 
COPSAC2010: 
age 1 month 
Colonized 
(total n) 
Colonized, 
median [IQR] mg/L 
Non-colonized, 
median [IQR] mg/L 
GMR 
[95%CI] 
P 
Culture data 234 (860) - - 1.49  
[1.25 – 1.78] 
<0.01 
Adjusted for current 
infections 
206 (772) - - 1.45 
[1.21 – 1.74] 
<0.01 
Adjusted for siblings 234 (860) - - 1.24 
[1.03 – 1.50] 
0.02 
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Table 3. Association between bacterial airway colonization and levels of hs-CRP in children with 
no infections before time of blood sampling in COPSAC2000 and COPSAC2010 
COPSAC2000 
 
Colonized 
(total n) 
Colonized, 
median [IQR]  
mg/L 
Non-colonized, 
median [IQR]  
mg/L 
GMR 
[95%CI] 
P 
Culture data, age 1 
month 
32 (128)  0.10 
 
[0.05 – 0.48] 
 0.89 
 
[0.05 – 0.48] 
1.39 
[0.89 – 2.18] 
0.15 
qPCR data, age 1 month 58 (113)  0.14 
 
[0.05 – 0.46] 
 0.80 
 
[0.03 – 0.19] 
1.60 
[1.12 – 2.29] 
0.01 
 
COPSAC2010 
 
Colonized 
(total n) 
Colonized, 
median [IQR] mg/L 
Non-colonized, 
median [IQR] mg/L 
GMR 
[95%CI] 
P 
Culture data, age 1 
month 
137 (455)  0.14 
 
[0.06 – 0.49] 
 0.08 
 
[0.04 – 0.28] 
1.50 
[1.18 – 1.90] 
<0.01 
Culture data, age 3 
months 
185 (348)  0.14 
 
[0.06 – 0.45] 
 
0.08 
 
[0.04 – 0.53] 
1.50 
[1.20 – 1.88] 
<0.01 
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Table 4. Multi-parametric analysis of the association between bacterial airway colonization and 
principle component 1 from a principle component analysis of hs-CRP, TNF-a and IL-6, which 
explains 55.4% of the variation in the data. 
 
COPSAC2000: 
age 1 month 
Colonized, 
culturing 
(total n) 
Estimate  [95%CI] P 
Principal component 1  52 
(238) 
1.4  [1.0–1.9] 0.04 
Adjusted for current 
infections 
52 
(238) 
1.3  [0.9 – 1.8] 0.12 
Adjusted for siblings 52 
(238) 
1.1 [0.7 – 1.7] 0.60 
 
 Colonized, qPCR 
(total n) 
Estimate [95%CI] P 
Principal component 1 84 
(246) 
1.5  [1.2–1.9] <0.01 
Adjusted for current 
infections 
84 
(246) 
1.5 [1.2 – 2.1] <0.01 
Adjusted for siblings 84 
(246) 
1.35 [0.96 – 1.9] 0.08 
COPSAC2010: 
age 1 month 
Colonized, 
culturing 
(total n) 
Estimate [95%CI] P 
Principal component 1 182 (622) 1.4  [1.2 – 1.7] <0.01 
Adjusted for current 
infections 
182 (622) 1.5 [1.2 – 1.9] < 0.01 
Adjusted for siblings 182 (622) 1.3 [1.0 – 1.6] 0.02 
COPSAC2010: 
age 3 months 
Colonized, 
culturing  
Estimate [95%CI] P 
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(total n) 
Principal component 1 264 (613) 1.5  [1.2 – 1.7] <0.01 
Adjusted for current 
infections 
224 (526) 1.6 [1.3 – 1.9] <0.01 
Adjusted for siblings 264 (613) 1.3 [1.1 – 1.6] <0.01 
 
FIGURE LEGENDS 
Figure 1: hs-CRP levels at age 6 months in children with vs. without early life bacterial airway 
colonization. The horizontal lines depict group median. 
Figure 2: Combined analysis of bacterial airway colonization detected by traditional culturing 
technique in both cohorts at age 1 month and hs-CRP level at age 6 months. 
Figure 3: Principal component analysis biplots incorporating hs-CRP, IL-6 and TNF-α levels at age 6 
months in relation to early life bacterial airway colonization in the COPSAC2000 (panel A) and 
COPSAC2010 (panel B) birth cohorts. Each point in the panel corresponds to a child. Two points 
closely related indicates children with similar profiles. The ellipses reflect the two-dimensional 
distribution of the group of children colonized (red) vs. children not colonized (blue) with 
pathogenic airway bacteria.  
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